Skip to content

Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections

Chlorhexidine-Alcohol Versus Povidone-Iodine for Surgical-Site Antisepsis:A Prospective, Randomized, Multicenter Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00290290
Enrollment
849
Registered
2006-02-13
Start date
2003-09-30
Completion date
2008-05-31
Last updated
2014-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Wound Infection

Keywords

Prevention, Antiseptic Preoperative Scrub, Postoperative Wound Infection

Brief summary

Most cases of infection of clean-contaminated wounds (wounds without gross spillage of organisms from the gastrointestinal tract) are thought to originate from the skin. Therefore, it is conceivable that application of an optimal antiseptic agent can reduce the rate of surgical wound infections. This trial is to compare the impact of disinfecting the skin with Chloraprep (2%chlorhexidine and 70% isopropyl alcohol) vs. Betadine on the rates of infection of clean-contaminated surgical wounds. The study will also assess the occurrence of adverse effects on the skin from either antiseptic agent and the cost-savings associated with the use of Chloraprep vs Betadine.

Detailed description

This is a prospective, randomized, multicenter clinical trial. All adult patients, who are scheduled for a clean-contaminated surgical procedure of the alimentary, respiratory, reproductive or urinary tract will be asked to participate.

Interventions

Preoperative skin preparation with scrub and paint technique

DRUGPovidone-Iodine

preoperative skin preparation with scrub and paint technique

Sponsors

Michael E. DeBakey VA Medical Center
CollaboratorFED
Medical College of Wisconsin
CollaboratorOTHER
US Department of Veterans Affairs
CollaboratorFED
Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult patients who are scheduled for a clean-contaminated surgical procedure of the alimentary or respiratory tract will be eligible for participation. A clean-contaminated wound is one that is entered under controlled conditions without unusual contamination. \-

Exclusion criteria

Patients will be excluded form the study if: (1) they are unable or unwilling to give informed consent; (2) the patient is less than 18 years of age; (3) there is evidence of pre-existing infection at or adjacent to the operative site; (4) a break in sterile technique occurs; (5) the patient has a history of allergy to chlorhexidine, alcohol or iodophors. \-

Design outcomes

Primary

MeasureTime frameDescription
The Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated Surgical Wounds.during surgery and within the 30 days post surgeryThe primary end point of the study was the occurrence of any surgical-site infection. Diagnosis of surgical-site infection was diagnosed by a blinded reviewer following criteria developed by the Center for Disease Control. The significance of difference between the two study groups in terms of patient characteristics was determined with the use of the Wilcoxon rank-sum test for continuous variables and Fisher's exact test for categorical variables. For efficacy outcomes, we compared the proportions of patients in the two study groups who could be evaluated and who any type of surgical-site infection using Fisher's exact test and calculating the relative risk of infection and 95% confidence intervals. To determine whether the results were consistent across the 6 participating hospitals, a prespecified Breslow-Day test for homogeneity was performed.

Countries

United States

Participant flow

Recruitment details

Patients 18 years or older undergoing clean-contaminated surgery preformed without substantial spillage or unusual contamination were eligible for enrollment. Patients were excluded if they were allergic to chlorhexidine, alcohol, or iodophors, or had infection at or adjacent to operative site, & if there was a perceived inability for a 30 days F/U

Pre-assignment details

There were no significant events prior to group assignment. Enrolled patients were immediately and randomly assigned in a 1:1 ratio to a study arm. To help match the two groups and address potential inter-hospital differences, randomization was stratified by hospital with the use of computer-generated randomization numbers without blocking

Participants by arm

ArmCount
Povidone-iodine
Skin at surgical site preoperatively scrubbed then painted with an aqueous solution of 10% povidone-iodine
440
Chlorhexidine-alcohol
Skin at surgical site preoperatively scrubbed with an applicator that contained 2% chlorhexidine gluconate and 70% alcohol
409
Total849

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath34
Overall StudyUnderwent clean surgical procedure1312
Overall StudyWithdrawal by Subject22

Baseline characteristics

CharacteristicPovidone-iodineChlorhexidine-alcoholTotal
Age, Continuous52.9 years
STANDARD_DEVIATION 14.2
53.3 years
STANDARD_DEVIATION 14.6
53.1 years
STANDARD_DEVIATION 14.4
Age, Customized
<18 years
0 participants0 participants0 participants
Age, Customized
>18 years
440 participants409 participants849 participants
Region of Enrollment
United States
440 participants409 participants849 participants
Sex: Female, Male
Female
194 Participants168 Participants362 Participants
Sex: Female, Male
Male
246 Participants241 Participants487 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 4403 / 409
serious
Total, serious adverse events
3 / 4404 / 409

Outcome results

Primary

The Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated Surgical Wounds.

The primary end point of the study was the occurrence of any surgical-site infection. Diagnosis of surgical-site infection was diagnosed by a blinded reviewer following criteria developed by the Center for Disease Control. The significance of difference between the two study groups in terms of patient characteristics was determined with the use of the Wilcoxon rank-sum test for continuous variables and Fisher's exact test for categorical variables. For efficacy outcomes, we compared the proportions of patients in the two study groups who could be evaluated and who any type of surgical-site infection using Fisher's exact test and calculating the relative risk of infection and 95% confidence intervals. To determine whether the results were consistent across the 6 participating hospitals, a prespecified Breslow-Day test for homogeneity was performed.

Time frame: during surgery and within the 30 days post surgery

ArmMeasureValue (NUMBER)
Povidone-IodineThe Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated Surgical Wounds.16.1 Percentage of Post Operative Infections
Chlorhexidine-AlcoholThe Primary Objective of This Trial is to Compare the Impact of Disinfecting the Skin With Chloraprep vs. Betadine on the Rates of Infection of Clean-contaminated Surgical Wounds.9.5 Percentage of Post Operative Infections
Comparison: The average baseline rate of surgical-site infection at the six participating hospitals was 14% after clean-contaminated surgery with povidone-iodine skin preparation, and we estimated that substituting chlorhexidine-alcohol for povidone-iodine would reduce this rate to 7%. Therefore, we planned to enroll approximately 430 patients in each study group who could be evaluated in order for the study to have 90% power to detect a significant difference in the rates of surgical-site infection.p-value: 0.00495% CI: [0.41, 0.85]Log Rank

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026